Detalles de la búsqueda
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048793
2.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129136
3.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161271
4.
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial.
Gynecol Oncol
; 168: 62-67, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401942
5.
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
Int J Gynecol Cancer
; 33(4): 577-584, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631150
6.
Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Int J Mol Sci
; 24(18)2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762649
7.
Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery.
Gynecol Oncol
; 165(2): 393-400, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331571
8.
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.
Gynecol Oncol
; 167(1): 11-21, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970603
9.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123771
10.
CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancer.
Int J Gynecol Cancer
; 32(8): 1071-1075, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321888
11.
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.
Int J Gynecol Cancer
; 2022 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858711
12.
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast Cancer Res
; 23(1): 79, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34344426
13.
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Int J Cancer
; 148(8): 1895-1909, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368296
14.
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
Gynecol Oncol
; 163(1): 64-71, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34294414
15.
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
Gynecol Oncol
; 163(2): 274-280, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452745
16.
Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer.
Arch Gynecol Obstet
; 303(5): 1295-1304, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33389113
17.
A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer.
Gynecol Oncol
; 158(3): 614-621, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709536
18.
Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Int J Gynecol Cancer
; 30(2): 233-240, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796531
19.
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Int J Cancer
; 144(8): 1962-1974, 2019 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30303537
20.
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Breast Cancer Res Treat
; 177(3): 659-667, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297647